26 research outputs found
Clinical characteristics of the study cohort.
<p>Clinical characteristics of the study cohort.</p
Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study - Fig 1
<p><b>Annual trends of the rates of (A) pharmacological prophylaxis and (B)</b> ≥ <b>10 days of pharmacological prophylaxis in patients who underwent TKA or THA between 2009 and 2013.</b> Abbreviations: TKA, total knee arthroplasty; THA, total hip arthroplasty; APC, annual percentage change</p
The incidence of venous thromboembolism within 3 months of TKA/THA between 2009 and 2013.
<p>The incidence of venous thromboembolism within 3 months of TKA/THA between 2009 and 2013.</p
Incidence of venous thromboembolism based on the pharmacological thromboprophylaxis status.
<p>Incidence of venous thromboembolism based on the pharmacological thromboprophylaxis status.</p
Incidence of venous thromboembolism based on the length of pharmacological thromboprophylaxis.
<p>Incidence of venous thromboembolism based on the length of pharmacological thromboprophylaxis.</p
Red blood cell transfusions based on the pharmacological agents used.
<p>Red blood cell transfusions based on the pharmacological agents used.</p
Univariate and multivariate analyses to identify independent risk factors for venous thromboembolism development in the study cohort.
<p>Univariate and multivariate analyses to identify independent risk factors for venous thromboembolism development in the study cohort.</p
The incidence of VTE according to clinical parameters.
*<p>Fisher's exact test, <sup>†</sup>linear-by-linear association.</p>‡<p>Subtotal gastrectomy was conducted in 271 patients and proximal gastrectomy in 11 patients.</p><p>Abbreviations: VTE, venous thromboembolism; BMI, body mass index; WBC, white bleed cell.</p
Characteristics of patients who developed VTE during postoperative periods.
<p>Abbreviations: VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism; LMWH, low molecular weight heparin.</p